-
公开(公告)号:US20220144848A1
公开(公告)日:2022-05-12
申请号:US17416274
申请日:2019-12-18
发明人: Susanne ROEHRIG , Sebastian ESSIG , Pascal ELLERBROCK , Sonja ANLAUF , Thomas NEUBAUER , Alexander HILLISCH , Katharina MEIER , Stefan HEITMEIER , Adrian TERSTEEGEN , Martina SCHAFER , Jan STAMPFUSS , Dieter LANG , Eloisa JIMENEZ NUNEZ , Jens ACKERSTAFF , Henrik TELLER , Zengqiang ZOU , Ping LIU , Xianghai MENG , Frank LESSMANN
IPC分类号: C07D491/044
摘要: The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular vascular disorders, preferably thrombotic or thromboembolic disorders and/or thrombotic or thromboembolic complications.
-
公开(公告)号:US20200339567A1
公开(公告)日:2020-10-29
申请号:US16758751
申请日:2018-10-18
发明人: Daniel MEIBOM , Jutta MEYER , Karl COLLINS , Nuria ORTEGA HERNANDEZ , Jan STAMPFUSS , Frank WUNDER , Till FREUDENBERGER , Thomas MONDRITZKI , Nina Alexandra SCHEERER , Kirsten LEINEWEBER , Jens SCHAMBERGER , Alexander STRAUB , Kersten Matthias GERICKE , Walter KROH , Mario LOBELL , Klaus MÜNTER
IPC分类号: C07D471/04 , C07D519/00 , A61K31/444 , A61K45/06 , A61P9/10 , A61K31/437
摘要: The present application relates to novel substituted imidazopyridine amides of the formula (I), to processes for their preparation, to their use, alone or in combinations, for the treatment and/or prophylaxis of diseases and to their use for the production of medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular, neurological and central nervous as well as metabolic disorders.
-
公开(公告)号:US20230024752A1
公开(公告)日:2023-01-26
申请号:US17504243
申请日:2021-10-18
发明人: Eloisa JIMENEZ NUNEZ , Jens ACKERSTAFF , Susanne ROEHRIG , Alexander HILLISCH , Katharina MEIER , Stefan HEITMEIER , Adrian TERSTEEGEN , Jan STAMPFUSS , Pascal ELLERBROCK , Daniel MEIBOM , Dieter LANG
IPC分类号: C07D401/10 , C07D401/14 , C07D413/14 , C07D413/10 , A61P7/02
摘要: The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.
-
-